| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2022 | A switch from tenofovir to entecavir prior to hepatitis B treatment cessation is associated with a reduced risk of off-therapy relapse: An observational study | Peng, CW; Jeng, WJ; Yang, HI ; Liu, YC; Chien, RN; Liaw, YF | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 37(11), 2164-2172 | | | |
| 2017 | Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients | Lee, MH; Huang, CF; Lai, HC; Lin, CY; Dai, CY; Liu, CJ; Wang, JH; Huang, JF; Su, WP; Yang, HC; Kee, KM; Yeh, ML; Chuang, PH; Hsu, SJ; Huang, CI; Kao, JT; Chen, CC; Chen, SH; Jeng, WJ; Yang, HI; Yuan, Y; Lu, SN; Sheen, IS; Liu, CH; Peng, CY; Kao, JH; Yu, ML; Chuang, WL; Chen, CJ | Scientific reports 7, 3718 | | | |
| 2019 | Discrepant range of sPD-1 in different studies of chronic hepatitis B. A letter in response to Soluble programmed death-1 is a useful indicator for inflammatory and fibrosis severity in chronic hepatitis B. | Jeng, WJ; Yang, HI | Journal of viral hepatitis 26(7), 930-930 | | | |
| 2019 | Genetic Factors That Affect Spontaneous Clearance of Hepatitis C or B Virus, Response to Treatment, and Disease Progression. | O'Brien, TR; Yang, HI ; Groover, S; Jeng, WJ | Gastroenterology 156(2), 400-417 | | | |
| 2022 | Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection | Wu, HC; Jeng, WJ; Pan, MH; Hsieh, YC; Lu, SN; Chen, CJ ; Yang, HI | JHEP reports : innovation in hepatology 4(2), 100410 | | | |
| 2019 | Interferon Is Superior to Direct Acting Antiviral Therapy in Tertiary Prevention of Early Recurrence of Hepatocellular Carcinoma. | Teng, W; Jeng, WJ; Yang, HI ; Chen, WT; Hsieh, YC; Huang, CH; Lin, CC; Lin, CY; Lin, SM; Sheen, IS | Cancers 12(1), 23 | | | |
| 2024 | Persistently high HBsAg levels during HBeAg-seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients | Lin, HC; Jeng, WJ; Liu, J; Pan, MH; Lee, MH; Batrla-Utermann, R; Lu, SN; Chen, CF; Yang, HI ; Chen, CJ | ALIMENTARY PHARMACOLOGY & THERAPEUTICS 59(8), 993-1002 | | | |
| 2023 | Rapid decline rather than absolute level of HBsAg predicts its seroclearance in untreated chronic hepatitis B patients from Taiwanese communities | Lin, HC; Liu, J; Pan, MH; Lee, MH; Batrla-Utermann, R; Lu, SN; Jeng, WJ; Yang, HI ; Chen, CJ | CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY 14(8), e00586 | | | |
| 2023 | Serum HBcrAg and hepatocellular carcinoma in a Taiwanese population seronegative for HBsAg and anti-HCV | Hsieh, YC; Pan, MH; Jeng, WJ; Hu, HH; Liu, J; Mizokami, M; Chen, CJ ; Yang, HI | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 21(5), 1303-1313 | | | |
| 2022 | Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B | Hu, HH; Jeng, WJ; Pan, MH; Luo, WS; Chang, CL; Huang, YT ; Su, CY; Chiang, CT; Jen, CL; Chien, YC; Lu, SN; Wang, LY; Huang, LR; Lee, MH; Liu, J; Nguyen, MH; Chen, CJ ; Yang, HI | ALIMENTARY PHARMACOLOGY & THERAPEUTICS 55(5), 558-567 | | | |
| 2022 | Serum soluble programmed death-1 levels predict the spontaneous HBeAg seroclearance in chronic hepatitis B | Chu, YJ; Jeng, WJ; Pan, MH; Hu, HH; Luo, WS; Su, CY; Chiang, CT; Jen, CL; Chen, CJ ; Yang, HI | Journal of Gastroenterology 57, 423-432 | | | |
